197 related articles for article (PubMed ID: 15170434)
21. Hormone replacement therapy in women with a history of breast cancer.
Ylikorkala O; Metsä-Heikkilä M
Gynecol Endocrinol; 2002 Dec; 16(6):469-78. PubMed ID: 12626034
[TBL] [Abstract][Full Text] [Related]
22. Use of alternative therapies in menopause.
Warren MP; Shortle B; Dominguez JE
Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):411-48. PubMed ID: 12099671
[TBL] [Abstract][Full Text] [Related]
23. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
24. [Indications for hormone replacement therapy].
Birkhäuser MH
Ther Umsch; 2000 Oct; 57(10):635-42. PubMed ID: 11081375
[TBL] [Abstract][Full Text] [Related]
25. Spanish Menopause Society position statement: use of tibolone in postmenopausal women.
Mendoza N; Abad P; Baró F; Cancelo MJ; Llaneza P; Manubens M; Quereda F; Sánchez-Borrego R
Menopause; 2013 Jul; 20(7):754-60. PubMed ID: 23793166
[TBL] [Abstract][Full Text] [Related]
26. A review of the effects of tibolone on the skeleton.
Devogelaer JP
Expert Opin Pharmacother; 2004 Apr; 5(4):941-9. PubMed ID: 15102576
[TBL] [Abstract][Full Text] [Related]
27. [Phytoestrogens--an alternative to hormonal replacement therapy].
Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
[TBL] [Abstract][Full Text] [Related]
28. [Alternatives to hormone replacement therapy: raloxifene and tibolone].
von Holst T
Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):205-9. PubMed ID: 10802895
[TBL] [Abstract][Full Text] [Related]
29. [Phytoestrogens].
Zittermann A
Zentralbl Gynakol; 2003 Jun; 125(6):195-201. PubMed ID: 14556117
[TBL] [Abstract][Full Text] [Related]
30. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
Levis S; Strickman-Stein N; Doerge DR; Krischer J
Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
[TBL] [Abstract][Full Text] [Related]
31. Tibolone: a unique version of hormone replacement therapy.
Swegle JM; Kelly MW
Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
[TBL] [Abstract][Full Text] [Related]
32. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
Kenemans P; Speroff L;
Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of conventional hormone replacement therapy and tibolone on climacteric symptoms and sexual dysfunction in postmenopausal women.
Ziaei S; Moghasemi M; Faghihzadeh S
Climacteric; 2010 Apr; 13(2):147-56. PubMed ID: 19731119
[TBL] [Abstract][Full Text] [Related]
34. [Selective estrogen receptor modulators in treatment of postmenopausal osteoporosis].
Meczekalski B; Czyzyk A
Ginekol Pol; 2009 Mar; 80(3):213-7. PubMed ID: 19382614
[TBL] [Abstract][Full Text] [Related]
35. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
[TBL] [Abstract][Full Text] [Related]
36. [Postmenopausal osteoporosis].
László A
Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
Bjarnason NH
Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
[No Abstract] [Full Text] [Related]
38. Prescribing of hormone therapy for menopause, tibolone, and bisphosphonates in women in the UK between 1991 and 2005.
Watson J; Wise L; Green J
Eur J Clin Pharmacol; 2007 Sep; 63(9):843-9. PubMed ID: 17598097
[TBL] [Abstract][Full Text] [Related]
39. Osteoporosis & Menopausal Disorders-SMi Conference.
Foley P
IDrugs; 2003 Jul; 6(7):660-3. PubMed ID: 12908451
[No Abstract] [Full Text] [Related]
40. Effects of tibolone on the breast of postmenopausal women.
Wang PH; Cheng MH; Chao HT; Chao KC
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
